Migraine in Children Recruiting Phase 2 Trials for Dihydroergotamine (DB00320)

IndicationStatusPhase
DBCOND0116907 (Migraine in Children)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03885154Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric MigraineTreatment